Company Profile
Certara Stock Price, News & Analysis
- Ticker:
- CERT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
8.13 USD (+1.50%)
Close
Last updated: August 6, 2026
874M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CERT closed up 1.50% at $8.13. No new same-company headline was identified in the current news window.
Company overview
Model-Informed Drug Development
Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios.
Software Portfolio
The company's software includes pharmacokinetic, pharmacodynamic, quantitative-systems-pharmacology and clinical-trial simulation applications. Customers use these products to inform dose selection, study design and regulatory submissions. Certara serves pharmaceutical and biotechnology companies, academic institutions and regulators. Its business combines recurring software subscriptions with scientific consulting and implementation services.
Future catalysts
Certara's catalysts are Simcyp adoption, model-informed drug-development bookings, and life-science software demand. The business improves when pharma customers keep using the platform as part of their everyday development workflow.
Recent news
- 01
Certara Reports Second Quarter 2026 Financial Results
Source: Certara
- 02
- 03
- 04
Certara Announces CFO Transition
Source: Certara
- 05
Certara to Participate in Upcoming Investor Conferences
Source: Certara
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Certara (CERT)?
Certara (CERT) most recently closed at 8.13 USD, a +1.50% move versus the previous session.
What is the market cap of Certara (CERT)?
Certara currently has a market capitalization of 874M USD on BioPharmSignal.
What does Certara do?
Model-Informed Drug Development Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios. Software Portfolio The company's software includes pharmacokinetic, pharmacodynamic,...
On which exchange is CERT stock listed?
Certara (CERT) is associated with NASDAQ, United States, Biopharma.
What is Model-Informed?
Certara's catalysts are Simcyp adoption, model-informed drug-development bookings, and life-science software demand.
Which conditions is Certara targeting with Model-Informed?
Certara's catalysts are Simcyp adoption, model-informed drug-development bookings, and life-science software demand.
How does Certara describe recent progress with Model-Informed?
Certara's catalysts are Simcyp adoption, model-informed drug-development bookings, and life-science software demand.
What is Drug?
Model-Informed Drug Development Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review.